FBXO31 Antibody (YA7869)(PBS only)

(Synonyms: FBX14; Fbx31; FBXO14; MRT45; pp2386)

FBXO31 Antibody (YA7869) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to FBXO31.

For research use only. We do not sell to patients.
  • Host:

    Mouse

  • Isotype:

    IgG2b

  • Application:

    ICC/IF, FC

  • Reactivity :

    Human, Mouse, Rat

  • Formulation:

    Supplied in PBS, pH 7.4.

  • Conjugation:
    Non-conjugated

Applications

Application
ICC/IF Info
ICC/IF: Immunocytochemistry/
Immunofluorescence
FC Info
FC: Flow Cytometry
Dilution Ratio 1:100-250 1:100

Product Details

Description

FBXO31 Antibody (YA7869) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to FBXO31.

  • Host Mouse
  • Species Reactivity
    Human, Mouse, Rat
  • Calculated Molecular Weight Predicted band size: 60.5 kDa
Immunogen

Full length human recombinant protein of human FBXO31 produced in HEK293T cell.

Purification

Affinity purified

Conjugation

Non-conjugated

Isotype

IgG2b

Product Properties

  • Appearance

    Liquid

  • Formulation

    Supplied in PBS, pH 7.4.

  • Storage & Stability

    Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

  • Shipping

    Shipping with blue ice.

Background

  • Function

    FBXO31 is a Substrate-recognition component of the SCF(FBXO31) protein ligase complex, which specifically mediates the ubiquitination of proteins amidated at their C-terminus in response to oxidative stress, leading to their degradation by the proteasome. FBXO31 specifically recognizes and binds C-terminal peptides bearing an amide: C-terminal amidation in response to oxidative stress takes place following protein fragmentation. The SCF(FBXO31) also plays a role in G1 arrest following DNA damage by mediating ubiquitination of phosphorylated cyclin-D1 (CCND1), promoting its degradation by the proteasome, resulting in G1 arrest. The SCF(FBXO31) complex is however not a major regulator of CCND1 stability during the G1/S transition. In response to genotoxic stress, the SCF(FBXO31) complex directs ubiquitination and degradation of phosphorylated MDM2, thereby promoting p53/TP53-mediated DNA damage response. SCF(FBXO31) complex is required for genomic integrity by catalyzing ubiquitination and degradation of cyclin-A (CCNA1 and/or CCNA2) during the G1 phase. In response to genotoxic stress, the SCF(FBXO31) complex directs ubiquitination and degradation of phosphorylated FBXO46 and MAP2K6. SCF(FBXO31) complex promotes ubiquitination and degradation of CDT1 during the G2 phase to prevent re-replication. The SCF(FBXO31) complex also mediates ubiquitination and degradation of DUSP6, OGT and PARD6A[1][2][3][4][5][6][7][8][9][10][11].

  • Subcellular Localization

    Cytoplasm,Cytoplasm, cytoskeleton, microtubule organizing center, centrosome

  • Expression


    Tissue_Specificity: Highly expressed in brain. Expressed at moderate levels in most tissues, except bone marrow
    Induction: By DNA damage. Increases after UV irradiation, X-ray irradiation, oxidative stress (H(2)O(2)) or addition of the chemotherapeutic DNA-damaging agents etoposide, adriamycin, cisplatin or fluorouracil

  • Isoforms & Post-Translational Modification

    Q5XUX0 has two isomers: Q5XUX0-1: 60664 Da (predicted); Q5XUX0-2: 49039 Da (predicted).
    Phosphorylation at Ser-278 by ATM following gamma-irradiation results in its stabilization (PubMed:19412162)丨Ubiquitinated by the SCF(FBXO46) complex in absence of stress, promoting its degradation (PubMed:30171069)

  • Subunit

    Part of a SCF (SKP1-cullin-F-box) protein ligase complex SCF(FBXO31) composed of CUL1, SKP1, RBX1 and FBXO31 (PubMed:16357137, PubMed:19412162, PubMed:31413110, PubMed:39880951)

  • SwissProt ID

    Q5XUX0

  • Synonyms

    FBX14; Fbx31; FBXO14; MRT45; pp2386

FBXO31 Antibody (YA7869)(PBS only) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00